$RichWire Markets and money, explained simply

LIVE

06:26 Northeast Community Bancorp Posts Fourth Straight Quarter of Missed Expectations 06:25 Unlocking Hidden Value: Examining SNDL's US Asset Strategy 06:09 Gold Faces Downward Pressure as Strong Inflation Data Strengthens the Dollar 06:08 Nuclear SMR Developer X-Energy Goes Public at $23 per Share 06:08 Accelevation Reaffirms 2026 Guidance in First Earnings Call Following Public Debut 06:00 Bitcoin Risks Further Fall Toward $40,000 as Analyst Warns of December Capitulation 06:00 Building a $600,000 Dividend Portfolio With Systematic ETF Investing 05:42 Pinterest Valuation Faces Pressure as Growth Slows Amid AI Disruption Fears 05:35 Honeywell Aerospace Posts $4.6 Billion in Third-Quarter Sales on Strong Commercial Demand 05:34 Bitcoin Teeters Near $65,000 Support as ETF Outflows and Miner Stress Mount 05:22 Gold Nears Key Support at 3850 as Analysts Weigh Recovery Potential 05:12 GBP/JPY Faces Downward Pressure After Channel Breakdown 06:26 Northeast Community Bancorp Posts Fourth Straight Quarter of Missed Expectations 06:25 Unlocking Hidden Value: Examining SNDL's US Asset Strategy 06:09 Gold Faces Downward Pressure as Strong Inflation Data Strengthens the Dollar 06:08 Nuclear SMR Developer X-Energy Goes Public at $23 per Share 06:08 Accelevation Reaffirms 2026 Guidance in First Earnings Call Following Public Debut 06:00 Bitcoin Risks Further Fall Toward $40,000 as Analyst Warns of December Capitulation 06:00 Building a $600,000 Dividend Portfolio With Systematic ETF Investing 05:42 Pinterest Valuation Faces Pressure as Growth Slows Amid AI Disruption Fears 05:35 Honeywell Aerospace Posts $4.6 Billion in Third-Quarter Sales on Strong Commercial Demand 05:34 Bitcoin Teeters Near $65,000 Support as ETF Outflows and Miner Stress Mount 05:22 Gold Nears Key Support at 3850 as Analysts Weigh Recovery Potential 05:12 GBP/JPY Faces Downward Pressure After Channel Breakdown

Topic: Liven Pharma

Technical Outlook: Liven Pharma Faces Key Resistance Level

🧠AI Analysis

AI Analysis6 h ago

Technical Outlook: Liven Pharma Faces Key Resistance Level

Liven Pharma shares show signs of a potential bullish reversal, though the stock must clear a critical resistance barrier to confirm further gains.

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.